M05.A

Clinical Causes: The exact cause of rheumatoid arthritis remains unknown; however, it is considered an autoimmune disease where the immune system mistakenly attacks healthy joint tissue. Factors contributing to its development include: - Genetic predisposition - Environmental influences such as smoking or exposure to certain pollutants - Hormonal factors - Certain infections may trigger immune responses The presence of abnormal rheumatoid factor and anti-citrullinated protein antibodies suggests an immune system disturbance that targets joint tissues, leading to inflammation and joint damage.

Key Symptoms: Common symptoms associated with rheumatoid arthritis and specific to cases with abnormal RF and ACPAs include: - Persistent joint pain and tenderness - Swelling and inflammation of joints, notably in the hands and feet - Symmetrical joint involvement - Morning stiffness lasting more than an hour - Fatigue and general feelings of malaise - Development of joint deformities over time It may also include systemic symptoms such as fever, weight loss, or anemia, especially during active phases of the disease.

Diagnosis Path: Diagnosis primarily involves a combination of clinical examination and laboratory tests. Key diagnostic approaches include: - Blood tests to detect rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPAs) - Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) tests to assess inflammation levels - Imaging studies like X-rays, ultrasound, or MRI to evaluate joint damage and inflammation - Comprehensive assessment of symptoms and physical findings to rule out other conditions The detection of abnormal RF and ACPAs specifically indicates a more aggressive disease course and can influence treatment decisions.

Treatment Protocols: While there is no cure for rheumatoid arthritis, various treatments aim to control symptoms, reduce inflammation, and prevent joint damage. Typical approaches include: - Disease-modifying antirheumatic drugs (DMARDs): such as methotrexate, sulfasalazine, and leflunomide - Biologic agents that target specific parts of the immune system, like TNF inhibitors - Nonsteroidal anti-inflammatory drugs (NSAIDs) to relieve pain and reduce inflammation - Corticosteroids for short-term control of severe flare-ups - Physical therapy and occupational therapy to maintain joint function and improve quality of life - Regular monitoring and adjustments to therapy based on disease activity and side effects Effective management often requires a multidisciplinary approach, highlighting the importance of tailored treatment plans.